tiprankstipranks
Advertisement
Advertisement
InMed Pharmaceuticals announces preclinical data on effects of INM-901
PremiumThe FlyInMed Pharmaceuticals announces preclinical data on effects of INM-901
19d ago
InMed Pharmaceuticals files $50M mixed securities shelf
Premium
The Fly
InMed Pharmaceuticals files $50M mixed securities shelf
22d ago
InMed outlines 2026 development plans for lead programs
Premium
Company Announcements
InMed outlines 2026 development plans for lead programs
1M ago
InMed Faces Challenges from New U.S. Legislation
PremiumCompany AnnouncementsInMed Faces Challenges from New U.S. Legislation
4M ago
InMed Pharmaceuticals Completes Key Study for INM-901
Premium
Company Announcements
InMed Pharmaceuticals Completes Key Study for INM-901
5M ago
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
Premium
The Fly
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
5M ago
InMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas
PremiumCompany AnnouncementsInMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas
6M ago
InMed Pharmaceuticals: Advancing Cannabinoid-Based Therapies
Premium
Company Announcements
InMed Pharmaceuticals: Advancing Cannabinoid-Based Therapies
7M ago
Trump links Tylenol use to autism, AutoZone reports downbeat Q4: Morning Buzz
Premium
The Fly
Trump links Tylenol use to autism, AutoZone reports downbeat Q4: Morning Buzz
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100